Início › Câncer de Ovário › Michigan › Grand Rapids
Ensaios clínicos de Câncer de Ovário em Grand Rapids, MI
24 estudos para Câncer de Ovário estão buscando participantes em locais em Grand Rapids e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RecrutandoFase 2/3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Study of PHST001 in Advanced Solid Tumors
RecrutandoFase 1
- START Center for Cancer Research - Midwest, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RecrutandoFase 1/2
- BAMF Health, Grand Rapids
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RecrutandoFase 2
- Site 0228 - Corewell Health Medical Group West, Grand Rapids
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RecrutandoFase 2
- Research Site, Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecrutandoEstudo observacional
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- START Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- START Midwest, Grand Rapids
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutando
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RecrutandoFase 1
- START - Midwest, Grand Rapids
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecrutandoFase 1/2
- START Midwest, Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- START Midwest, Grand Rapids
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecrutandoFase 3
- Corewell Health, Grand Rapids
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
RecrutandoFase 2
- GSK Investigational Site, Grand Rapids
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
RecrutandoFase 2/3
- BAMF Health, Grand Rapids
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
RecrutandoFase 1
- START Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecrutandoFase 1/2
- START Midwest, Grand Rapids
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
Outros estudos em Grand Rapids
- Câncer de Pulmão de Não Pequenas Células44 estudos
- Câncer Colorretal40 estudos
- Câncer (todos os tipos)28 estudos
- Câncer de Mama26 estudos
- Câncer Metastático22 estudos
- Câncer de Próstata19 estudos
- Câncer Endometrial18 estudos
- Câncer de Estômago18 estudos
- Câncer de Pâncreas18 estudos
- Melanoma17 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço15 estudos
- Câncer de Mama Triplo-Negativo15 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.